SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950116-04-003583
Filing Date
2004-11-29
Accepted
2004-11-29 17:24:24
Documents
4
Period of Report
2004-07-31

Document Format Files

Seq Description Document Type Size
1 TENK-A.TXT tenk-a.txt 10-K/A 73165
2 EX31-1.TXT ex31-1.txt EX-31 4095
3 EX31-2.TXT ex31-2.txt EX-31 4143
4 EX32-2.TXT ex32-2.txt EX-32 1579
  Complete submission text file 0000950116-04-003583.txt   84859
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-25169 | Film No.: 041172629
SIC: 2834 Pharmaceutical Preparations